complications   108

« earlier    

Considering Low Contrast Complications - David Smith, Independent iOS Developer
“I’d also really like this option, if it ever appeared, to integrate with one of my favorite little easter eggs in watchOS, where you can turn the crown on the watch when it is dimmed to ‘peek’ at the watch face without fully illuminating the screen.”
applewatch  complications  underscore  2018 
october 2018 by handcoding
Glycemic control and vascular complications in type 2 diabetes mellitus - UpToDate
[tl;dr: Glycemic control improves microvascular outcomes in type 2 diabetes, including progression of nephropathy, manifestation and progression of retinopathy, and retinal photocoagulation; and showed a beneficial effect of intensive therapy on the development of more advanced clinical outcomes in renal disease and its precursors in the one study with long-enough follow up to assess effect. Cardiovascular risk benefit "has not been established as clearly" for type 2 as for type 1.]

Although the role of glycemic control on microvascular disease in type 2 diabetes was documented in the United Kingdom Prospective Diabetes Study (UKPDS), its role in reducing cardiovascular risk has not been established as clearly for type 2 diabetes....

improving glycemic control improves microvascular outcomes, as illustrated by the findings of a meta-analysis of randomized trials (34,912 participants) [5]. There was a reduction in the risk of microvascular complications (a composite outcome including progression of nephropathy, manifestation and progression of retinopathy, and retinal photocoagulation) in the intensive compared with standard glycemic control group (relative risk [RR] 0.88, 95% CI 0.82-0.95). There were significant reductions in risk for each of the individual components.

In other meta-analyses of trials (over 28,000 adults) evaluating the benefits of intensive versus conventional glycemic control specifically on renal outcomes, there was a statistically significant reduction in the risk of microalbuminuria and macroalbuminuria in patients randomly assigned to intensive glycemic control (risk ratios of 0.86 and 0.74, respectively) [6,7]. The reduction in risk of end-stage renal disease did not reach statistical significance (RR 0.69, 95% CI 0.46-1.05). There was no reduction in the risk of doubling of the serum creatinine level or death from renal disease (RRs 1.06 and 0.99, respectively) [6]. Of note, the majority of the trials in the meta-analyses were not of long enough duration to show a beneficial effect of glycemic control on end-stage renal disease, which typically manifests after 10 to 20 years of diabetes duration [8]. In the trials included in the meta-analyses, the absolute rates of severe renal outcomes were low in both the intensive- and conventional-therapy groups, reducing the ability of the analysis to demonstrate a benefit, if one exists. In the one trial with longer-term follow-up (United Kingdom Prospective Diabetes Study [UKPDS] cohort followed for 22 years), there was a beneficial effect of intensive therapy on the development of more advanced clinical outcomes, including renal disease
type  2  T2D  diabetes  risk  tight  management  glucose  control  blood  benefit  morbidity  mortality  microvascular  complications  kidneys  eyes  retinopathy  nephropathy  renal  disease  cardiovascular  peer-reviewed  research  review  meta-analysis  overview  in  vivo  situ  human  clinical  trial  symptoms  comorbidities  self  treatment  care 
september 2018 by Michael.Massing
Glycemic Control in Nonpregnant Adults With Type 2 Diabetes | Guidelines | JAMA | JAMA Network
[As is so often the case, the discussion of treatment risk vs. benefit in glycemic control/management is distorted by an actually or effectively exclusive focus on drug therapy. —DMM]

In the United States, type 2 diabetes affects 30 million people and is a major cause of morbidity and mortality.1 Glycemic control has been shown to reduce diabetes complications, particularly for microvascular disease.2,3 However, increasing recognition of adverse events due to intensive diabetes treatments has prompted major disagreements about optimal glycemic targets.
glycemic  control  tight  management  glucose  complications  late-stage  symptoms  risk  mitigation  prevention  microvascular  diabetes  type  2  T2D  drug  therapy  treatment  peer-reviewed  research  in  vivo  situ  human  clinical  trial  blood  benefit  comorbidities  morbidity  self  care  behavioral 
july 2018 by Michael.Massing

« earlier    

related tags

1  2  2003  2010  2010s  2011  2013  2018  2019  27c3  38mm  3rd  4  512  a1c  ace  acids  addiction  adiposity  adverse  african-american  after  aggressive  aids  airpollution  alan  alcohol  aluminum  amino  analog  analysis  and  api  apnea  apple  applewatch  apps  aps-c  arb  archive  arthroplasty  asd  astronomy  augmentation  aviation  baby  bad  band  base_jumping  battery  behavior  behavioral  believable  benefit  bernstein  best  bestpractice  beta  bigdata  biological  biology  blasey  bloch  blogged  blood  body  bond  bone  bookmarks_menu  bp  breast  breastfeeding  breathing  camera  cancer  cardiology  cardiovascular  care  caregiver  causeofdeath  cell  change  chart  cheiroarthropathy  chicago  child  cholesterol  christine  circulation  cited  clinical  clkcomplicationdatasource  clockkit  coding  color  colors  community  comorbidities  complexity  complicated  complication  conference  conplicated  control  controversial  cooperative  correlation  counseling  criteria  critique  culture  cusromize  customization  customize  cutoff  cvd  dairy  daly  damage  danish  data  dataanalysis  david  dcct  death  decision  decisions  delta  denmark  dental  design  desktop  develop  development  diabetes  diabetesincontrol  diabetic  diagnosis  diarrhea  dies  diet  dietary  digital  disability  disease  disorder  disorientation  disparities  display  dr  dressing  drug  drugs  dsease  dying  dysglycemia  dyslipidemia  earth  economics  ecstacy  education  effectiveness  effects  efficacy  end-stage  endocrine  engine  environment  environmental  epidemiology  epigenetics  etiology  events  ever!  ever  example  excursions  exercise  expert  eye  eyes  face  faces  factor  failure  familial  fasting  fat  fats  fibrates  film  first  fitness  fleuoroestimer  fluctuation  fob  foods  foot  for  ford  fpg  freak  fuji  fujifilm  gbd2010  gear  genetic  genetics  genome  get  gizmodo  glances  global  globalburdenofdiseasesinjuriesandriskfactorsstudy  glucose  glycemic  goals  google  grafting  graph  graphics  guide  hackett  hands  harddisk  harm  have  headaches  health  healthcare  heart  heartdisease  high  highbloodpressure  highrisk  history  hiv  homescreen  hospital  howto  human  hypertension  hypoglycemia  hypothesis  ihme  illness  image  images  impaired  implant  implants  imported_ie_favorites  impressions  in  incentive  incentives  indicators  inheritance  inhibitor  injection  injury  instituteforhealthmetricsandevaluation  insulin  intensive  international  intervention  ios  isoleucine  jason  joslin  june  kidney  kidneys  lancet  laser  lasik  late-stage  late  left.out  leucine  life  lifeexpectancy  lifespan  links  linux  lipids  literacy  longevity  longitudinal  look  loss  lows  macsparky  made  magnesium  management  maximum  may  mcr  mdma  mechanism  medical  medicine  mentoring  meta-analysis  metabolic  metabolicsyndrome  metafilter_posts  metrics  mg  microalbuminaria  microvascular  mikey/alicia  mikey/pete/alicia  mikey/pete  minority  mirrorless  mitigation  monitoring  moon  morbidity  more  mortality  most  msk  multifactorial  multimodal  musculoskeletal  myth  nardin  nejm  nephropathy  nerves  neuropathy  no  normal  number  nyt  obesity  of  off  one  ophthalmologist  organ  outcome  outcomes  overview  parachuting  parenting  party  peer-reviewed  peer  performance  perth  pharmaceuticals  phase  phenylalanine  phone  photo  photographer  photography  photos  pill  pining!pete  pining  pixels  plastic  pocket  point  police  pollution  postprandial  prediabetes  predisposition  pregnancy  premature  pressure  prevalence  prevention  prognostic  progression  protection  provider  public  publichealth  quality  qualityoflife  ras  reference  remediation  remission  renal  renin-angiotensin  repair  reporting  research  resistance  retina  retinopahy  retinopathy  review  revision  richard  risk  rough  safety  sanitation  science  search  security  seizure  self-monitored  self  sequelae  series  ses  setup  side  situ  six  sleep  smbg  smoking  snell  social  socioeconomic  solar  sore  sources  sparks  spero  sport  squirrel_suit  ssl  standards  statins  statistics  status  stephen  streaming  stroke  study  sugar  sun  sundial  supplements  support  surgeon  surgery  survival  susceptibility  symptoms  system  systems  t1d  t2d  target  tech  telephone  termperature  testing  the  thelancet  theory  therapy  thoughts  threesome  threshold  throat  tight  timeline  timepiece  tipping  to  tobacco  toolongfpp  treatment  trial  truth  tutorial  tutorials  type  type2diabetes  tyrosine  ui  uidesign  ulcers  ulysse  underdiagnosis  underscore  unfinished  utility  valine  variability  viewfinder  vision  visualization  vivo  vte  watch  watches  watchface  watchkit  watchos  watchos2  watchos4  water  wear  weekend  what.i'm.reading  wingsuit  work  worldwide  x100  x100t  ybrid  your  |   

Copy this bookmark: